Capital Management Lp Camber serves as Executive at AMAG PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Capital Management Lp Camber has executed 7 insider transactions totaling $71.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 2, 2024 involved selling 525,000 shares valued at $9.3M.
Capital Management Lp Camber currently holds 2,725,000 shares of AMAG PHARMACEUTICALS, INC. (AMAG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Management Lp Camber has been a net seller of AMAG stock. They have purchased $3.0M and sold $68.9M worth of shares.
Capital Management Lp Camber's most recent insider trade was on Aug 2, 2024, when they sold 525,000 shares at $17.71 per share.
Get notified when new Form 4 filings are submitted
| $13.57 |
| Discretionary |
| Aug 9, 2019 | AMAG | $31.2K | Purchase | 3,400 | $9.18 | Discretionary |
| Aug 9, 2019 | AMAG | $237.8K | Purchase | 26,600 | $8.94 | Discretionary |
| Aug 7, 2019 | AMAG | $2.3M | Purchase | 301,000 | $7.79 | Discretionary |
| Aug 7, 2019 | AMAG | $387.0K | Purchase | 50,000 | $7.74 | Discretionary |
| Aug 7, 2019 | AMAG | $30.3K | Purchase | 4,000 | $7.58 | Discretionary |